Home / Stocks / INBX

INBX insider trading

Inhibrx Biosciences, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$3.7M
Buys · last 90 days
0 · $0
Most recent buy
2024-11-22

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-10-09HALVORSEN OLE ANDREAS
10% owner
Sold308,643$32.25$10.0M
2024-11-22Kayyem Jon Faiz
Director
Bought107,186$14.22$1.5M
2024-10-07Vuori Kristiina MD
Director
Bought6,667$15.00$100k
2024-09-16Lappe Mark
Chief Executive Officer
Bought40,000$15.73$629k
2024-09-12Vuori Kristiina MD
Director
Bought6,636$15.07$100k
2024-09-10Lappe Mark
Chief Executive Officer
Bought44,000$15.25$671k
2024-09-03Lappe Mark
Chief Executive Officer
Bought40,000$14.92$597k
2024-09-03Vuori Kristiina MD
Director
Bought7,140$14.00$100k

Most active insider buyers

InsiderRoleBuysTotal bought
Lappe MarkChief Executive Officer3$1.9M
Kayyem Jon FaizDirector1$1.5M
Vuori Kristiina MDDirector3$300k

See INBX on the chart

Every insider buy and sell for INBX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.